Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 8/20 | 0.77 |
| ▸ | MMP2 | P08253 | 7/20 | 0.77 |
| ▸ | MMP3 | P08254 | 7/20 | 0.77 |
| ▸ | MMP1 | P03956 | 7/20 | 0.77 |
| ▸ | MMP9 | P14780 | 7/20 | 0.77 |
| ▸ | MMP7 | P09237 | 6/20 | 0.77 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7380440 | 1.00 | MMP13 (0.77) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL32691800 | 0.91 | MMP2 (0.80) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL7419690 | 0.86 | MMP2 (0.91) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL3973093 | 0.85 | MMP2 (0.82) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL21451101 | 0.85 | MMP2 (0.82) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL6561375 | 0.85 | MMP2 (0.82) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL1770811 | 0.83 | MMP1 (0.67) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL12649188 | 0.83 | MMP1 (0.67) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL7082523 | 0.82 | MMP2 (1.00) | MMP13MMP2MMP3MMP1MMP9 | |
| SCHEMBL7376000 | 0.82 | MMP9 (0.74) | MMP13MMP2MMP3MMP1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934267-B1 | ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | UPJOHN CO (US) | 2002-01-30 | — | — | EP | claimed |
| EP-0934267-A1 | $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1999-08-11 | — | — | EP | claimed |
| US-5804593-A | FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. | PHARMACIA & UPJOHN COMPANY (US) | 1998-09-08 | — | — | US | claimed |
| WO-1998017645-A1 | α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1998-04-30 | — | — | WO | claimed |
| EP-0934267-B1 | ALPHA-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | UPJOHN CO (US) | 2002-01-30 | — | — | EP | disclosed |
| EP-0934267-A1 | $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| US-5804593-A | FOR TREATMENT OF CONNECTIVE TISSUE DEGRADATION, OSTEO-, RHEUMATOID-, AND SEPTIC ARTHRITIS; OSTEOPENIAS, OSTEOPOROSIS, CORNEAL ULCERATION, PERIDONTAL DISEASE, GASTRIC ULCERS. | PHARMACIA & UPJOHN COMPANY (US) | 1998-09-08 | — | — | US | disclosed |
| WO-1998017645-A1 | α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS | PHARMACIA & UPJOHN COMPANY (US) | 1998-04-30 | — | — | WO | disclosed |